TherapeuticsMD (TXMD) FCF Margin Growth (1y) (2012 - 2026)
TherapeuticsMD (TXMD) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 4,962.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,962.00 |
| Mar 31, 2026 | -4,748.00 |
| Dec 31, 2025 | 3,944.00 |
| Sep 30, 2025 | 14,040.00 |
| Jun 30, 2025 | -58,092.00 |
| Mar 31, 2025 | 25,103.00 |
| Dec 31, 2024 | 155,287.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 128,662.00 |
| Mar 31, 2024 | 202,299.00 |
| Dec 31, 2023 | -158,331.00 |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | 528,260.00 |
| Mar 31, 2023 | 48,140.00 |
| Dec 31, 2022 | -22,401.00 |
| Sep 30, 2022 | 515,469.00 |
| Jun 30, 2022 | -583,275.00 |
| Mar 31, 2022 | -238,404.00 |
| Dec 31, 2021 | 39,220.00 |
| Sep 30, 2021 | 2,593.00 |